PTEN and neoplasm: Various other specific miRNAs, such as miR-19a in leukemia, miR-22 in prostate cancer, and miR-26a in high-grade gliomas, have been identified as influential in modulating PTEN expression and impacting tumor dynamics, with effects varying by cancer type [21-23].